Part,  Chapter, Paragraph

 1   II,     5.  2.  7|        in the last year of life. Arch Intern Med 165:1028-34.~
 2   II,     5.  2.  7|         Borderline Risk Factors. Arch Intern Med. 167:573-579.~
 3   II,     5.  5.  3|           facts and visions. Eur Arch Psychiatry Clin Neurosci
 4   II,     5.  5.  3| schizophrenia: a re-examination. Arch Gen Psychiatry 62(3):247-
 5   II,     5.  5.  3|         gap worsening over time? Arch Gen Psychiatry 64(10):1123-
 6   II,     5.  5.  3|   between research and care. Eur Arch Psychiatry Clin Neurosci
 7   II,     5.  5.  3|   fatigue in multiple sclerosis. Arch Phys Med Rehabil 65:135-
 8   II,     5.  5.  3|       and prevalence in Ferrara. Arch Neurol 53:793-798.~Gross
 9   II,     5.  5.  3|   Fatigue in multiple sclerosis. Arch Neurol 45:435-437.~Kurtzke
10   II,     5.  5.  3|        Italy, 1967 through 1987. Arch Neurol 48(8):854-857.~Hely
11   II,     5.  8.  7|          population-based study. Arch Bronconeumol 40: 72-79.~ ~
12   II,     5. 14.  1|           allows adequate dental arch space for the eruption of
13   II,     9.  1.  1|          French county, 1980-91. Arch Dis Child 2003;88(2):114-
14   II,     9.  1.  2|          of Congenital Anomaly”, Arch Dis Childh, Vol 82, pp 349-
15   II,     9.  1.  2|        structural birth defects. Arch Paed Adolesc Med 2007; 161:
16   II,     9.  3.  2|          French county, 1980-91. Arch Dis Child 2003;88(2):114-
17   II,     9.  3.  3|      risk in Sweden (1989-2003). Arch Sex Behav 34:219-29.~Hessling
18  III,    10.  1.  3|     Confounding and interaction. Arch Dermatol 136(12):1544-6.~
19  III,    10.  2.  5|       thinness during childhood. Arch Gen Psychiatry 2001;58(1):
20  III,    10.  6.  1|     relations and heart disease. Arch Intern Med 167(18):1951-